HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Bayley, D. L. Articles by Stockley, R. A. PubMed PubMed Citation Articles by Bayley, D. L. Articles by Stockley, R. A.

Validation of assays for inflammatory mediators in exhaled breath condensate

¹ Dept of Medicine, University of Birmingham, and ² Queen Elizabeth Hospital, Birmingham, UK.

CORRESPONDENCE: D. L. Bayley, Dept of Medicine, University of Birmingham, Edgbaston, Birmingham, B15 2TH, UK. Fax: 44 1216272012. E-mail: bayleydl{at}hotmail.com

Keywords: ₁-Antitrypsin, exhaled breath condensate, interleukin-8, leukotriene B₄, myeloperoxidase, secretory leukoprotease inhibitor

Received: July 3, 2007
Accepted January 12, 2008

The use of exhaled breath condensate (EBC) as a tool for noninvasive assessment of lung inflammation is becoming commonplace. Many authors use commercial ELISA kits to measure inflammatory mediators within EBC. However, the very low concentrations of mediators within EBC are often below the commercially validated concentration range of the relevant ELISA and crucially below the linear part of the sigmoid standard curve. The present study seeks to validate a series of assays for use in EBC and to compare the results in EBC with those from matched sol phase sputum samples.

The following mediators were measured by ELISA: leukotriene (LT)B₄, interleukin (IL)-8, secretory leukoprotease inhibitor and ₁-antitrypsin (AAT). Myeloperoxidase was measured by chromogenic substrate assay.

Mediator concentrations reached the lower limit of quantification in only one assay (AAT) in 19.6% of subjects, while mediator concentrations reached the lower limit of detection in three assays (LTB₄, IL-8 and AAT in 31, 6.5 and 61% of subjects, respectively). No significant correlations were present between any mediators in EBC and sol phase sputum.

The results of the present study indicate that care must be exercised when interpreting mediator measurements in exhaled breath condensate and that assays must be validated at concentrations relevant to those found within the biological fluid.